Hawkins
Blends chemicals and ingredients for water treatment, food, health, and industrial customers.
Something off on this page? Send us feedback.
Profile
Formulates, manufactures, blends, and distributes chemicals and specialty ingredients for water treatment, food and health sciences, and industrial markets. Water treatment is the largest segment, combining chemicals with equipment, engineered systems, rentals, and technician-supported delivery across a growing U.S. branch network.
Formulates, manufactures, blends, and distributes chemicals and specialty ingredients through Water Treatment, Food and Health Sciences, and Industrial Solutions. Water Treatment combines treatment chemicals with filtration media, equipment, engineered systems, rentals, and technician-supported delivery for municipal, industrial, pool, and agricultural water customers, mainly across the eastern two-thirds of the United States.
Food and Health Sciences supplies nutrition, food, pharmaceutical, and agricultural manufacturers with ingredients, formulation, processing, and blending. Industrial Solutions handles acids, alkalis, custom blends, and repackaged bulk chemicals through plants and terminals. Shared raw materials and facilities support purchasing efficiency, while acquisitions broaden the water-treatment footprint. Operations depend on chemical availability, logistics, integration, and environmental, safety, transport, storage, and product regulation.
Company facts
Key statistics
Year to date −17.2% · Average volume (30d) 156.9K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Barclays | Reiterate | Equal Weight | $170 | $142 | |
| Jun 30, 2026 | Barclays | Target | $170 | |||
| Apr 14, 2025 | BWS Financial | Upgrade | Neutral | Buy | ||
| Oct 16, 2024 | BWS Financial | Downgrade | Buy | Neutral |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026Q1 FY27 | $1.39 | $1.35 | −2.9% | $313.4M | $315.7M | +0.7% | −6.77% |
| May 13, 2026Q4 FY26 | $0.76 | $0.74 | −2.6% | $255.3M | $265.9M | +4.2% | −3.25% |
| Jan 28, 2026Q3 FY26 | $0.75 | $0.72 | −4.0% | $252.5M | $244.1M | −3.3% | −9.11% |
| Oct 29, 2025Q2 FY26 | $1.24 | $1.08 | −12.9% | $259.9M | $280.4M | +7.9% | −5.04% |
Financial highlights
| 12 quarters | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|
| Revenue | $245.3M | $293.3M | $280.4M | $244.1M | $265.9M | $315.7M | |
| Gross profit | $48.7M | $72.4M | $67.6M | $50.8M | $54.2M | $74.0M | |
| Operating income | $24.9M | $39.8M | $34.5M | $18.8M | $22.1M | $38.7M | |
| Net income | $16.3M | $29.2M | $22.6M | $14.3M | $15.5M | $28.3M | |
| Diluted EPS | $0.78 | $1.40 | $1.08 | $0.69 | $0.74 | $1.35 | |
| Gross margin | 19.8% | 24.7% | 24.1% | 20.8% | 20.4% | 23.4% | |
| Operating margin | 10.2% | 13.6% | 12.3% | 7.7% | 8.3% | 12.3% |
Fiscal years (4-quarter sums)FY22 $774.5M · FY23 $935.1M · FY24 $919.2M · FY25 $974.4M · FY26 $1.08B
Revenue by product · Q1 FY27
Balance sheet, Jun 28, 2026Cash & short-term investments $8.0M · Total debt $260.7M · Total assets $1.01B · Shareholders' equity $548.2M
Dividends
Raised for 6 straight years — most recently to $0.20 from $0.19 in Aug 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 14, 2026 | Aug 14 | Aug 28 | $0.20 | raised from $0.19 |
| May 29, 2026 | May 29 | Jun 12 | $0.19 | |
| Feb 13, 2026 | Feb 13 | Feb 27 | $0.19 | |
| Nov 14, 2025 | Nov 14 | Nov 28 | $0.19 | |
| Aug 15, 2025 | Aug 15 | Aug 29 | $0.19 | raised from $0.18 |
| May 30, 2025 | May 30 | Jun 13 | $0.18 | |
| Feb 14, 2025 | Feb 14 | Feb 28 | $0.18 | |
| Nov 15, 2024 | Nov 15 | Nov 29 | $0.18 |
Ownership
Shares outstanding 20.88M · Float 19.14M · 91.7% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 3.16M | 15.14% | 13F | Aug 7, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 1.43M | 6.84% | 13F | Aug 13, 2026 |
| State Street Corporation | 1.06M | 5.10% | 13G | Aug 7, 2026 |
| Vanguard Capital Management LLC | 854.5K | 4.09% | 13F | Aug 13, 2026 |
| Geode Capital Management, LLC | 547.5K | 2.62% | 13F | Aug 12, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 25, 2026 | Douglas A. Lange | officer: VP - WATER TREATMENT GROUP | +910 | $118.75 |
| Feb 4, 2026 | James A. Faulconbridge | director | +1,500 | $129.29 |
| Feb 5, 2026 | James A. Faulconbridge | director | +1,500 | $129.95 |
| Nov 3, 2025 | Drew M. Grahek | officer: VICE PRESIDENT OF OPERATIONS | +1,587 | $126.34 |
Peers
- Ecolab
Broad water, hygiene, and food-safety service overlap
- Xylem
Water equipment, filtration, and service systems
- Olin
Chlor-alkali producer against bulk chemical supply
- Ingredion
Food, nutrition, and industrial ingredient solutions
- Balchem
Nutrition, pharma, and specialty performance ingredients
- Sensient Technologies
Colors, flavors, and pharma ingredient systems
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Hawkins | $120.35 | +0.10% | $2.51B | 31.2 | 28.6 | 2.3 | +7.6% |
| Ecolab | $275.05 | −4.11% | $80.70B | 38.5 | 33.2 | 4.8 | +9.7% |
| Xylem | $112.64 | +1.19% | $25.99B | 26.5 | 18.9 | 2.8 | +1.5% |
| Olin | $17.26 | +0.64% | $1.95B | — | 51.4 | 0.3 | −0.9% |
| Ingredion | $104.00 | −0.54% | $6.60B | 11.4 | 9.5 | 0.9 | +0.9% |
| Balchem | $178.44 | −0.06% | $5.73B | 35.1 | 32.1 | 5.3 | +11.2% |
| Sensient Technologies | $135.12 | 0.00% | $5.75B | 36.4 | 30.4 | 3.4 | +11.6% |
| Median | 35.1 | 31.3 | 3.1 | +5.6% |